Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 18.05MWorking Capital
VS
Market
Sector
Industry
History
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information
Ticker
PMCBCompany Name
PHARMACYTE BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHARMACYTE BIOTECH INC - Working Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PMCB - Working Capital Historical data
| Date | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| 6/30/2025 | $ 19.11M | $ 1.06M | $ 18.05M |
| 3/31/2025 | $ 22.38M | $ 2.91M | $ 19.46M |
| 12/31/2024 | $ 16.96M | $ 1.19M | $ 15.77M |
| 9/30/2024 | $ 21.33M | $ 4.78M | $ 16.56M |
| 6/30/2024 | $ 32.88M | $ 7.47M | $ 25.4M |
| 3/31/2024 | $ 50.44M | $ 7.42M | $ 43.02M |
| 12/31/2023 | $ 61.51M | $ 7.54M | $ 53.97M |
| 9/30/2023 | $ 73.75M | $ 5.24M | $ 68.51M |
| 6/30/2023 | $ 74.75M | $ 1.52M | $ 73.23M |
| 3/31/2023 | $ 68.15M | $ 586.58K | $ 67.56M |
Key Performance Insights, Last 5 Years
- PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) Working Capital stands at $ 3.17M.
- Over the past 5 years, PHARMACYTE BIOTECH INC's average Working Capital has been $ 44.82M.
- The median Working Capital for PHARMACYTE BIOTECH INC during this period was $ 48.49M
- PHARMACYTE BIOTECH INC reached its highest Working Capital over the past 5 years at $ 86.99M.
- The lowest Working Capital recorded by PHARMACYTE BIOTECH INC in the same timeframe $ 583.39K
Similar metrics to Working Capital:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Working Capital
[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].AssetsC - LiabilitesC
(=) Working Capital Working Capital for PHARMACYTE BIOTECH INC is calculated as follows: AssetsC [ $ 3.81M ] - LiabilitesC [ $ 643.65K ]
(=) Working Capital [ $ 3.17M ] PMCB - Working Capital, Last 5 years
$ 583.39K
Minimum
Jun 30, 2021
$ 86.99M
Maximum
Sep 30, 2021
$ 44.82M
Average
$ 48.49M
Median
Working Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.1M with a standard deviation of $ 174.5M.
The following table provides additional summary stats:
Working Capital in the Market:
| filtered constituents | 2.78K |
|---|---|
| min | $ -468.61M |
| max | $ 607.04M |
| average | $ 96.1M |
| median | $ 32.21M |
| std | $ 174.5M |